Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

[1]  K. Campbell,et al.  Basolateral Entry and Release of New and Old World Arenaviruses from Human Airway Epithelia , 2008, Journal of Virology.

[2]  C. Roth,et al.  New opportunities for field research on the pathogenesis and treatment of Lassa fever. , 2008, Antiviral research.

[3]  G. Poland,et al.  Flu myths: dispelling the myths associated with live attenuated influenza vaccine. , 2008, Mayo Clinic proceedings.

[4]  S. Peel,et al.  Blood genomic profiles of exposures to Venezuelan equine encephalitis in Cynomolgus macaques (Macaca fascicularis) , 2007, Virology Journal.

[5]  Rasha Hammamieh,et al.  Monkey Model for Lassa Fever Early Blood Profiles of Virus Infection in a Supplemental Material , 2007 .

[6]  I. Lukashevich,et al.  A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. , 2007, Vaccine.

[7]  S. Tardif,et al.  Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues , 2007, Journal of Virology.

[8]  I. Lukashevich,et al.  Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses , 2007, Virus Genes.

[9]  Igor S. Lukashevich and Maria S. Salvato.  Lassa Virus Genome , 2006 .

[10]  M. Wolfe,et al.  Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.

[11]  V. Deubel,et al.  A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. , 2006, Virology.

[12]  P. Darlu,et al.  Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. , 2006, The Journal of general virology.

[13]  I. Lukashevich,et al.  A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses , 2005, Journal of Virology.

[14]  B. Mothé,et al.  Development of a New Vaccine for the Prevention of Lassa Fever , 2005, PLoS medicine.

[15]  I. Lukashevich,et al.  Ribonucleic acids of Machupo and Lassa viruses , 2005, Archives of Virology.

[16]  K. Mansfield,et al.  GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. , 2004, The Journal of general virology.

[17]  J. McCormick,et al.  Lassa fever vaccine , 2004, Expert review of vaccines.

[18]  A. Hoerauf,et al.  Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. , 2004, Virology.

[19]  Lassa fever: epidemiology, clinical features, and social consequences , 2004, BMJ : British Medical Journal.

[20]  I. Lukashevich,et al.  Arenavirus-Mediated Liver Pathology: Acute Lymphocytic Choriomeningitis Virus Infection of Rhesus Macaques Is Characterized by High-Level Interleukin-6 Expression and Hepatocyte Proliferation , 2003, Journal of Virology.

[21]  P. Jahrling,et al.  Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus , 2002, Journal of medical virology.

[22]  Philip K. Russell,et al.  Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.

[23]  P. Jahrling,et al.  Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses , 2001, Journal of Virology.

[24]  N. Seidah,et al.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. Hutwagner,et al.  Effective Vaccine for Lassa Fever , 2000, Journal of Virology.

[26]  A. Hoerauf,et al.  Characterization of Human CD4+ T-Cell Clones Recognizing Conserved and Variable Epitopes of the Lassa Virus Nucleoprotein , 2000, Journal of Virology.

[27]  I. Lukashevich,et al.  Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. , 1997, Virology.

[28]  I. Lukashevich,et al.  The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. , 1997, The Journal of general virology.

[29]  D. Brown,et al.  Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.

[30]  I. Lukashevich.  Generation of reassortants between African arenaviruses. , 1992, Virology.

[31]  S. Wilson,et al.  Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. , 1991, Virus research.

[32]  J. Saluzzo,et al.  Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. , 1990, Vaccine.

[33]  J. McCormick,et al.  Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. , 1986, Virology.

[34]  J. McCormick,et al.  Lassa virus hepatitis: a study of fatal Lassa fever in humans. , 1986, The American journal of tropical medicine and hygiene.

[35]  A. Anusz.  [Lassa fever]. , 1981, Pielegniarka i polozna.

[36]  T. Monath,et al.  Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone , 1974, Science.

[37]  J. Frame,et al.  Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. , 1970, The American journal of tropical medicine and hygiene.